GLOBAL DIRECT-FED MICROBIALS MARKET 2019-2028

MARKET OUTLOOK
Triton Market Research, in its report on the North American direct-fed microbials market, depicts that the industry is expected to flourish at a CAGR of 6.50% over the estimated period 2019-2028.
The United States and Canada together constitute the North American direct-fed microbials market.
In North America, with the growing human population, the demand for meat and milk production is also increasing. Hence, different growth promoters are used to increase milk and meat production in the region. This has boosted the demand for direct-fed microbials in North America. Antibiotics were initially used as growth promoters in animal production. But, there is a risk of antibiotic-resistant organisms. Hence, it was banned in some parts of the region. This lead to an increased opportunity for the direct-fed microbials market to grow.
Also, consumers are increasingly becoming aware of the benefits of using probiotic microbial strains, which has led to the rising demand for direct-fed microbials for animal production. Additionally, the extensive R&D activities towards the development of better strains to enhance animal production efficiency have significantly contributed to the growth of the studied market. In the United States, the animal feed and pet food manufacturing sector is an essential driver of economic activities. The pet ownership rates in the country are increasing rapidly, thereby driving the demand for direct-fed microbials.
COMPETITIVE OUTLOOK
Some noteworthy companies in the direct-fed microbials market are Novozymes, Chr. Hansen Holding A/S, Lallemand Inc, ProviCo Pty Ltd, Novus International Inc, Cargill Incorporated, Nutraferma and Protexin.

TABLE OF CONTENTS
1. NORTH AMERICA DIRECT-FED MICROBIALS MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1.MARKET DEFINITION
2.2.EVOLUTION & TRANSITION OF DIRECT-FED MICROBIALS
2.3.KEY INSIGHTS
2.3.1. POULTRY SEGMENT TO WITNESS ROBUST GROWTH
2.3.2. INCREASING LIVESTOCK SHARE IN AGRICULTURAL OUTPUT
2.3.3. GROWING AWARENESS REGARDING IMPACT OF ANIMAL HEALTH ON HUMANS
2.4.IMPACT OF COVID-19 ON DIRECT-FED MICROBIALS MARKET
2.5.PORTER’S FIVE FORCES ANALYSIS
2.5.1. THREAT OF NEW ENTRANTS
2.5.2. THREAT OF SUBSTITUTE
2.5.3. BARGAINING POWER OF BUYERS
2.5.4. BARGAINING POWER OF SUPPLIERS
2.5.5. THREAT OF COMPETITIVE RIVALRY
2.6.MARKET ATTRACTIVENESS INDEX
2.7.VENDOR SCORECARD
2.8.MARKET DRIVERS
2.8.1. DEMAND FOR MEAT & MILK
2.8.2. GROWING USAGE IN ANIMAL PRODUCTION MANAGEMENT
2.9.MARKET RESTRAINTS
2.9.1. COST CONSTRAINTS
2.10.MARKET OPPORTUNITIES
2.10.1. RISE IN CONCERNS REGARDING USE OF ANTIBIOTICS IN ANIMALS
2.10.2. GOVERNMENT INITIATIVES TO PROMOTE ANIMAL HEALTH PRODUCTS
2.11.MARKET CHALLENGES
2.11.1. DIFFERENT REGULATORY APPROACHES
3. NORTH AMERICA DIRECT-FED MICROBIALS MARKET OUTLOOK - BY TYPE
3.1.DRY FORM
3.2.LIQUID FORM
4. NORTH AMERICA DIRECT-FED MICROBIALS MARKET OUTLOOK - BY BACTERIA
4.1.LACTIC ACID BACTERIA
4.2.BACILLUS
4.3.OTHER BACTERIA
5. NORTH AMERICA DIRECT-FED MICROBIALS MARKET OUTLOOK - BY LIVESTOCK
5.1.POULTRY
5.2.SWINE
5.3.RUMINANTS
5.4.AQUATIC ANIMALS
5.5.OTHER LIVESTOCK
6. NORTH AMERICA DIRECT-FED MICROBIALS MARKET – REGIONAL OUTLOOK
6.1.UNITED STATES
6.2.CANADA
7. COMPETITIVE LANDSCAPE
7.1.NUTRAFERMA
7.2.PROTEXIN
7.3.PROVICO PTY LTD
7.4.KONINKLIJKE DSM NV
7.5.KEMIN INDUSTRIES INC
7.6.STRONG MICROBIALS INC
7.7.ARCHER DANIELS MIDLAND COMPANY
7.8.DUPONT
7.9.ADISSEO
7.10.BENTOLI INC
7.11.BIO-VET
7.12.CARGILL INCORPORATED
7.13.CHR. HANSEN HOLDING A/S
7.14.LALLEMAND INC
7.15.NOVOZYMES
7.16.NOVUS INTERNATIONAL INC
8. RESEARCH METHODOLOGY & SCOPE
8.1.RESEARCH SCOPE & DELIVERABLES
8.2.SOURCES OF DATA
8.3.RESEARCH METHODOLOGY

LIST OF TABLES
TABLE 1: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY STATUS OF DIRECT-FED MICROBIALS IN SOME COUNTRIES
TABLE 4: EFFECTS OF MICROBIAL STRAINS ON RUMINANT ANIMALS
TABLE 5: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, BY BACTERIA, 2019-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, BY LIVESTOCK, 2019-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)


LIST OF FIGURES
FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: WORLDWIDE MEAT CONSUMPTION, BY TYPE (KG PER CAPITA)
FIGURE 3: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, BY DRY FORM, 2019-2028 (IN $ MILLION)
FIGURE 4: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, BY LIQUID FORM, 2019-2028 (IN $ MILLION)
FIGURE 5: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, BY LACTIC ACID BACTERIA, 2019-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, BY BACILLUS, 2019-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, BY OTHER BACTERIA, 2019-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, BY POULTRY, 2019-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, BY SWINE, 2019-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, BY RUMINANTS, 2019-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, BY AQUATIC ANIMALS, 2019-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, BY OTHER LIVESTOCK, 2019-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA DIRECT-FED MICROBIALS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 14: UNITED STATES DIRECT-FED MICROBIALS MARKET 2019-2028 (IN $ MILLION)
FIGURE 15: CANADA DIRECT-FED MICROBIALS MARKET 2019-2028 (IN $ MILLION)